Clinical Trials Directory

Trials / Completed

CompletedNCT04142541

Evaluation of the 3-in-1 Neuroguard IEP System for Carotid Artery Stenosis

Protection Against Emboli During Carotid Artery Stenting Using a 3-in-1delivery System Comprised of a Post-dilation Balloon, Integrated Embolic Filter, and a Novel Carotid Stent (PERFORMANCE 1 Trial)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
67 (actual)
Sponsor
Contego Medical, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Neuroguard IEP System is a 3-in-1 carotid stent delivery system consisting of an angioplasty balloon, an integrated embolic protection device and a nitinol self-expanding stent loaded over the balloon and constrained by an outer sheath. The PERFORMANCE I study is a multi-center, prospective, single arm open label study to evaluate the safety and feasibility of the Neuroguard IEP System for the treatment of carotid artery stenosis. The primary endpoint will be the proportion of patients with Major Adverse Events (MAE) reported within 30 days from the index procedure. The primary objective of the PERFORMANCE I study is to evaluate the safety and feasibility of the Neuroguard IEP Carotid Stent System when used in patients with clinically significant carotid artery stenosis requiring revascularization.

Conditions

Interventions

TypeNameDescription
DEVICENeuroguard® IEP 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection (Neuroguard IEP System)The Neuroguard® IEP 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection is indicated for improving the carotid luminal diameter in patients with clinically significant carotid artery stenosis and for the simultaneous capture and removal of embolic material during angioplasty and stenting.

Timeline

Start date
2018-02-28
Primary completion
2019-03-18
Completion
2020-02-17
First posted
2019-10-29
Last updated
2022-11-21

Locations

6 sites across 2 countries: Germany, Italy

Source: ClinicalTrials.gov record NCT04142541. Inclusion in this directory is not an endorsement.